Tag: Paragraph IV certification
FDA's 180-Day Exclusivity: How It Helps First Generic Drug Makers Compete
FDA's 180-day exclusivity rewards the first generic drug maker to challenge a patent, but delays in launching can block competition and keep prices high. Here's how it works-and why reform is coming.
Read More